NAYA Biosciences executes 1-for-12 reverse stock split to regain Nasdaq compliance

INVO Fertility, Inc.

Reverse split effective 12:01 a.m. ET on March 18, 2025; stock trades under same symbol 'NAYA'.
Post-split shares outstanding approx. 666,057; authorized shares reduced to 4,166,666.
Fractional shares rounded up to next whole share; new CUSIP number 44984F609.
Split intended to meet Nasdaq $1.00 minimum bid price requirement for continued listing.
No assurance that reverse split will enable compliance with Nasdaq listing standards.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

INVO Fertility, Inc.: Amended certificate of incorporation to effect a 1-for-12 reverse stock split of common stock and adjust authorized shares from 50,000,000 to 4,166,667 (effective 2025-03-18).

Change: charter amendment
Effective: 2025-03-18

Exact text from the filing

On March 18, 2025, NAYA Biosciences, Inc. (the “Company”) filed a Certificate of Change (the “Certificate of Change”) with the Secretary of State of the State of Nevada to effectuate a 1-for-12 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding and authorized shares of common stock, par value $0.0001 per share (“Common Stock”).

View on SEC.gov

83 governance changes filed in the last 30 days. Browse all governance changes →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-000316

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.